Search results
Results from the WOW.Com Content Network
In July 2021, the U.S. Food and Drug Administration (FDA) approved Tanovea to treat lymphoma in dogs. [6] Lymphoma, also called lymphosarcoma, is a type of cancer that can affect many species, including dogs. [6] Rabacfosadine is the first conditionally approved new animal drug for dogs to achieve the FDA's full approval. [6]
The Consumer Health Product Database is a web-based application that allows the public to search for specific products or specific chemical ingredients. It is a collection of publicly available information, mostly from product labels and Safety Data Sheets (former MSDS) provided by the product's manufacturer. [ 1 ]
Food and Drug Administration Substance Registration System U.S. National Library of Medicine: ingredients in FDA regulated products UNII inchikey "FDA SRS". 781,000 FEMA Flavor Ingredient Library: Flavor and Extract Manufacturers Association: CAS CFR FEMA number "FEMA". FooDB: Food Database University of Alberta Food components and additives ...
Drug Manufacturer Indication Crizotinib: PF Prism: ALK-positive systemic anaplastic large cell lymphoma: Trastuzumab deruxtecan: Daiichi Sankyo: HER2-positive gastric or gastroesophageal junction adenocarcinoma, previously treated with trastuzumab: Umbralisib: TG Therapeutics: marginal zone lymphoma, previously treated with an anti-CD20-based ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Drugs.com is an online pharmaceutical encyclopedia that provides drug information for consumers and healthcare professionals, primarily in the United States. It self-describes its information as "accurate and independent" yet limited to being "for educational purposes only and is not intended for medical advice, diagnosis or treatment."
The FDA said in a statement that it had audited the plant for cause related to certain FDA approved products at the site and did not take or recommend regulatory or enforcement action, saying it ...
A biologics license application (BLA) is defined by the U.S. Food and Drug Administration (FDA) as follows: The biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680.